LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

Developing therapeutic monoclonal antibodies at pandemic pace

Photo by museumsvictoria from unsplash

The time from discovery to proof-of-concept trials could be reduced to 5–6 months from a traditional timeline of 10–12 months. Click to show full abstract

The time from discovery to proof-of-concept trials could be reduced to 5–6 months from a traditional timeline of 10–12 months.

Keywords: pandemic pace; monoclonal antibodies; therapeutic monoclonal; antibodies pandemic; developing therapeutic

Journal Title: Nature Biotechnology
Year Published: 2020

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.